🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06680323
Recruiting Observational

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

NCT06680323 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-01-01
Last updated
2024-11-08

Condition(s) studied

MelanomaSpitzoid MelanomaCongenital Nevi

Study summary

The primary objective of this study is the identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA). The secondary objectives are to generate a model integrating the genetic and environmental factors to estimate the risk of developing melanoma and improve the primary prevention of melanoma through evidence-based interpretation of environmental risk.

Eligibility

Sex
ALL
Min age
—
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria: * confirmed melanoma * age until 30 years old Exclusion Criteria: * no available biological material * no signed informed consent

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Leibniz Research Institute for Environmental Medicine Düsseldorf Germany Active Not Recruiting
University of Florence Florence Italy Active Not Recruiting
Istituto Nazionale del Tumori Milan Italy Active Not Recruiting
Medical University of Gdánsk Gdansk Poland Recruiting
Hospital Clínic de Barcelona Barcelona Spain Recruiting
Karolinska Institute Solna Sweden Recruiting

More University Hospital Tuebingen trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06680323 on ClinicalTrials.gov ↗ ← All trials in Germany